THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.
About this episode
(00:31):
Before we get started, can you tell us a little bit about yourselves and your backgrounds?
(02:35):
Can you guys give us a brief overview of this assay and what will be changing to characterize marijuana use?
(04:28):
So which patients should have this testing and when would you say it should be performed, Dr. Langman?
(05:58):
Are there other test options available and if, and if so, how do these compare?
(07:03):
This is really the best way to accurately characterize marijuana use. Would you say that's true?
(07:11):
And then could you, Dr. Langman, explain how the results are used in patient care?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab
Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab